Seaport upgrades Ralliant stock rating on sales trends, raises target to $88

Seaport Global upgraded Ralliant Corp to Buy with a $88.00 price target, implying 21.0% upside from the Oct 13 close. The analyst cites strong sales, earnings performance, and an optimistic outlook with improved earnings estimates for 2026 and 2027, driven by effective execution and cost reductions.

Evercore ISI raised its price target for Ralliant Corp. to $85.00, citing improved margin projections for its sensors & safety systems segment. The firm increased its 2027-28 adjusted EBITA and EPS estimates, which are above consensus. Ralliant's Q2 2026 earnings beat expectations, with revenue up 13% and EBITDA margin improving by 390 basis points. The company also raised its full-year 2026 outlook.

Ralliant Corp (RAL) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Ralliant Reports Second Quarter 2026 Results and Raises Full Year Guidance • Revenue of $568 million, up 13% year-over-year with double-digit revenue growth in both segments • Net earnings margin of 10.1%; adjusted EBITDA margin of 19.8% • Net earnings per diluted sh

Genmab (GMAB) reported positive Phase 3 trial results for Petosemtamab combined with Keytruda in head and neck cancer, showing a 50% reduction in death risk and improved tumor response. The combination met primary endpoints and was well tolerated. GMAB plans regulatory discussions and further trials. The stock is up 28.89% at $57.53.

Visteon Corp (VC) shares fell 4% after announcing CFO Jerome Rouquet will depart by November 30, 2026. Colleen Myers, current VP and Chief Accounting Officer, will serve as interim CFO. The company is searching for a permanent successor. Rouquet has been with Visteon for six years. CEO Sachin Lawande expressed confidence in Myers' leadership during the transition.

UBS analysts rank nitrogen fertilizer producers favorably for 2027, citing demand and supply challenges. CF Industries (CF) is seen as the top beneficiary, with estimates raised. Nutrien (NTR) and Mosaic (MOS) are also analyzed, with mixed outlooks. UBS expects higher pricing into spring, despite concerns like Chinese exports and ammonia markets.